TTP and OS to the ≥2nd line cetuximab-containing treatment according to KRAS, BRAF, PIK3CA mutations status, PTEN protein expression, AREG and EREG mRNA expression and grade of skin rash in the whole patient′ population.
收藏数据链接：
官方服务：
资源简介：
*CI: Confidence Interval,#HR: Hazard Ration,∧WT: Wild Type,$Skin rash grade 2–3 vs. none,@Skin rash grade 2–3 vs. grade 1,&KRAS or BRAF WT and EREG overexpressed vs. KRAS or BRAF mutant and EREG downregulated,∞KRAS or BRAF WT and EREG overexpressed vs. KRAS or BRAF mutant and EREG overexpressed,£KRAS or BRAF WT and EREG overexpressed vs. KRAS or BRAF WT EREG downregulated.
创建时间：
2015-12-02
